From Genome to Therapy: Integrating New Technologies With Drug Development: 229 - Rilegato

Novartis Foundation; Symposium On From Genome To Therapy: Integrating New Technologies With Drug Development (1999 : Basel, Switzerland)

Rilegato

ISBN 10: 0471627445 ISBN 13: 9780471627449

Casa editrice: John Wiley & Sons Inc, 2000

Riassunto

This important and exciting work brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. Recent technological advances have led to a rapid acceleration in our ability to gather genetic data. The complete genetic sequences are now known for several organisms and accelerated programmes are in place for sequencing many other genomes, including human. The speed with which complete sequencing can be accomplished will continue to increase as new technologies come online. In principle, the scope for developing new diagnostic techniques and drugs is now greater than at any time in human history, but the pathway from genetic information to usable drug is a long and complex one.

This major book covers such subjects as the current state of the art in squencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomics from the point of view of the pharmaceutical industry.

Su questo libro

Informazioni sull?autore

The Novartis Foundation is an international scientific and educational charity which promotes the study and general knowledge of science and in particular encourages international co-operation in scientific research.

Dalla quarta di copertina

Recent technological advances have led to a rapid acceleration in our ability to gather genetic data. The complete genetic sequences are now known to several organisms and accelerated programmes are in place for sequencing many other genomes, including human. The speed with which complete sequencing can be accomplished will continue to increase as new technologies come online. In principle, the scope for developing new diagnostic techniques and drugs is now greater than at any time in human history, but the pathway from genetic information to usable drug is a long and complex one.

This exciting book brings together a high-calibre group of experts to discuss the practical application of genomic information to the development of drugs. The subjects covered include the current state of the art in sequencing technology, the applications of these new technologies to sequencing the genomes of various organisms, and the challenge of proteomics. Additional contributions deal with legal and ethical implications of the new uses of genetic data, and functional genomes from the point of view of the pharmaceutical industry.

Dettagli dell'edizione

• Editore: John Wiley & Sons Inc
• Data di pubblicazione: 2000
• Lingua: Inglese
• ISBN 10: 0471627445
• ISBN 13: 9780471627449
• Rilegatura: Copertina rigida
• Numero edizione: 1
• Numero di pagine: 165
• Redattore: Bock Gregory, Cohen Dalia, Goode Jamie
• Contatto del produttore: non disponibile
• Persona responsabile: non disponibile